163 related articles for article (PubMed ID: 8423345)
1. Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor.
Karp SE; Farber A; Salo JC; Hwu P; Jaffe G; Asher AL; Shiloni E; Restifo NP; Mulé JJ; Rosenberg SA
J Immunol; 1993 Feb; 150(3):896-908. PubMed ID: 8423345
[TBL] [Abstract][Full Text] [Related]
2. Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cells.
Alosco T; Croy BA; Gansbacher B; Wang HQ; Rao U; Bankert R
Cancer Immunol Immunother; 1993 Jun; 36(6):364-72. PubMed ID: 8500109
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.
Patel PM; Flemming CL; Russell SJ; McKay IA; MacLennan KA; Box GM; Eccles SA; Collins MK
Br J Cancer; 1993 Aug; 68(2):295-302. PubMed ID: 8347485
[TBL] [Abstract][Full Text] [Related]
4. Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells.
Ohno K; Yoshizawa H; Tsukada H; Takeda T; Yamaguchi Y; Ichikawa K; Maruyama Y; Suzuki Y; Suzuki E; Arakawa M
J Immunol; 1996 May; 156(10):3875-81. PubMed ID: 8621926
[TBL] [Abstract][Full Text] [Related]
5. IL-28 elicits antitumor responses against murine fibrosarcoma.
Numasaki M; Tagawa M; Iwata F; Suzuki T; Nakamura A; Okada M; Iwakura Y; Aiba S; Yamaya M
J Immunol; 2007 Apr; 178(8):5086-98. PubMed ID: 17404291
[TBL] [Abstract][Full Text] [Related]
6. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
[TBL] [Abstract][Full Text] [Related]
7. Insertion of the IL-2 gene decreases tumorigenicity of murine fibrosarcoma.
Kuśnierczyk H; Załecki P; Pajtasz-Piasecka E; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1998; 46(4):259-65. PubMed ID: 9779293
[TBL] [Abstract][Full Text] [Related]
8. Local secretion of IFN-gamma induces an antitumor response: comparison between T cells plus IL-2 and IFN-gamma transfected tumor cells.
Sadanaga N; Nagoshi M; Lederer JA; Joo HG; Eberlein TJ; Goedegebuure PS
J Immunother; 1999 Jul; 22(4):315-23. PubMed ID: 10404433
[TBL] [Abstract][Full Text] [Related]
9. Retroviral transduction of interferon-gamma cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor.
Shiloni E; Karp SE; Custer MC; Shilyansky J; Restifo NP; Rosenberg SA; Mulé JJ
Cancer Immunol Immunother; 1993 Oct; 37(5):286-92. PubMed ID: 8402732
[TBL] [Abstract][Full Text] [Related]
10. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J
Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
[TBL] [Abstract][Full Text] [Related]
11. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
[TBL] [Abstract][Full Text] [Related]
12. Involvement of T-cell subsets and natural killer (NK) cells in the growth suppression of murine fibrosarcoma cells transfected with interleukin-12 (IL-12) genes.
Schmitt M; Ikeda H; Nagata Y; Gu X; Wang L; Kuribayashi K; Shiku H
Int J Cancer; 1997 Jul; 72(3):505-11. PubMed ID: 9247296
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses.
Griffith TS; Kawakita M; Tian J; Ritchey J; Tartaglia J; Sehgal I; Thompson TC; Zhao W; Ratliff TL
J Natl Cancer Inst; 2001 Jul; 93(13):998-1007. PubMed ID: 11438565
[TBL] [Abstract][Full Text] [Related]
14. [Augmentation of vaccination effects of PGE2-producing tumor cells by transfection with cytokine genes].
Ohiro Y
Hokkaido Igaku Zasshi; 1997 May; 72(3):273-84. PubMed ID: 9226467
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of disseminated fibrosarcoma in mice using IL-2-producing tumor cells: studies on its mechanism and specificity.
Tsukada H; Yoshizawa H; Takeda T; Ohno K; Ichikawa K; Suzuki Y; Suzuki E; Wei ZG; Arakawa M; Gejyo F
Cancer Detect Prev; 1999; 23(6):524-33. PubMed ID: 10571663
[TBL] [Abstract][Full Text] [Related]
16. Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines.
Clary BM; Coveney EC; Blazer DG; Philip R; Lyerly HK
Surgery; 1996 Aug; 120(2):174-81. PubMed ID: 8751580
[TBL] [Abstract][Full Text] [Related]
17. Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha.
Marincola FM; Ettinghausen S; Cohen PA; Cheshire LB; Restifo NP; Mulé JJ; Rosenberg SA
J Immunol; 1994 Apr; 152(7):3500-13. PubMed ID: 8144931
[TBL] [Abstract][Full Text] [Related]
18. Human lung tumor cell secretion of interleukin-2 for protection against tumor engraftment.
Alosco T; Gansbacher B; Bankert R; Takita H; Petrelli N
Ann Surg Oncol; 1994 May; 1(3):229-35. PubMed ID: 7842293
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H
J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.
Hock H; Dorsch M; Kunzendorf U; Qin Z; Diamantstein T; Blankenstein T
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2774-8. PubMed ID: 8464888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
